Is attendant at delivery associated with the use of interventions to prevent postpartum hemorrhage at home births? The case of Bangladesh

BMC Pregnancy and Childbirth

Mohammad A Quaiyum²  Martine Holston⁴  Suzanne Bell¹  Ndola Prata³ 

[1] Bixby Center for Population, Health and Sustainability, School of Public Health, University of California at Berkeley, 17 University Hall, UC-Berkeley, Berkeley, CA 94720-7360, USA;icddr, b, Centre for Reproductive Health, GPO Box 128, Dhaka 1000, Bangladesh;Bixby Center for Population, Health and Sustainability, School of Public Health, University of California at Berkeley, 229 University Hall, UC-Berkeley, Berkeley, CA 94720-7360, USA;Venture Strategies Innovations, 2401 East Katella Avenue, Suite 400, Anaheim, California 92806, USA

关键词: Traditional birth attendant;    Home delivery;    Delivery mat;    Misoprostol;    Postpartum hemorrhage;    Maternal mortality;    Bangladesh;   

Others  :  1131768
DOI  :  10.1186/1471-2393-14-24

 received in 2013-06-20, accepted in 2014-01-06,  发布年份 2014

【 摘 要 】

Background

Hemorrhage is the leading cause of maternal mortality in Bangladesh, the majority of which is due to postpartum hemorrhage (PPH), blood loss of 500 mL or more. Many deaths due to PPH occur at home where approximately 77% of births take place. This paper aims to determine whether the attendant at home delivery (i.e. traditional birth attendant (TBA) trained on PPH interventions, TBA not trained on interventions, or lay attendant) is associated with the use of interventions to prevent PPH at home births.

Methods

Data come from operations research to determine the safety, feasibility, and acceptability of scaling-up community-based provision of misoprostol and an absorbent delivery mat in rural Bangladesh. Analyses were done using data from antenatal care (ANC) cards of women who delivered at home without a skilled attendant (N = 66,489). Multivariate logistic regression was used to assess the likelihood of using the interventions.

Results

Overall, 67% of women who delivered at home without a skilled provider used misoprostol and the delivery mat (the interventions). Women who delivered at home and had a trained TBA present had 2.72 (95% confidence interval, 2.15-3.43) times the odds of using the interventions compared to those who had a lay person present. With each additional ANC visit (maximum of 4) a woman attended, the odds of using the interventions increased 2.76 times (95% confidence interval, 2.71-2.81). Other sociodemographic variables positively associated with use of the interventions were age, secondary or higher education, and having had a previous birth.

Conclusion

Findings indicate that trained TBAs can have a significant impact on utilization of interventions to prevent PPH in home births. ANC visits can be an important point of contact for knowledge transfer and message reinforcement about PPH prevention.

【 授权许可】

   
2014 Prata et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]AbouZahr C: Global burden of maternal death and disability. Br Med Bull 2003, 67:1-11.
• [2]AbouZahr C: Antepartum and postpartum haemorrhage. In Health dimensions of sex and reproduction: the global burden of sexually transmitted diseases, HIV, maternal conditions, perinatal disorders, and congenital anomalies. Edited by Murray CJ, Lopez AD. Boston: Harvard University Press; 1998:172-174.
• [3]Ramanathan G, Arulkumaran S: Postpartum hemorrhage. J Obstet Gynaecol Can 2006, 28(11):967-973.
• [4]Prata N, Hamza S, Bell S, Karasek D, Vahidnia F, Holston M: Inability to predict postpartum hemorrhage: insights from Egyptian intervention data. BMC Pregnancy Childbirth 2011, 11:97. BioMed Central Full Text
• [5]National Institute of Population Research and Training (NIPORT), MEASURE Evaluation, UNC-CH, ICDDR B: Bangladesh maternal mortality and healthcare survey 2010: preliminary results. Dhaka: NIPORT; 2011.
• [6]Prata N, Passano P, Bell S, Rowen T, Potts M: New hope: community-based misoprostol use to prevent postpartum haemorrhage. Health Policy Plan 2012, 28(4):339-346.
• [7]Prendiville WJ, Elbourne D, McDonald S: Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev 2000., 3CD000007
• [8]Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, Wasim S, Walraven G, Hatcher J: Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG 2011, 118(3):353-361.
• [9]Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad MB, Patted SS, Patel A, Edlavitch SA, Hartwell T, et al.: Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet 2006, 368(9543):1248-1253.
• [10]Hoj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, Aaby P: Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 2005, 331(7519):723.
• [11]Prata N, Mbaruku G, Campbell M, Potts M, Vahidnia F: Controlling postpartum hemorrhage after home births in Tanzania. Int J Gynaecol Obstet 2005, 90(1):51-55.
• [12]Hashima EN, Nahar S, Al Mamun M, Afsana K, Byass P: Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it? Glob Health Action 2011., 4doi: 10.3402/gha.v4i0.7017
• [13]Prata N, Gessessew A, Abraha AK, Holston M, Potts M: Prevention of postpartum hemorrhage: options for home births in rural Ethiopia. Afr J Reprod Health 2009, 13(2):87-95.
• [14]Sanghvi H, Ansari N, Prata NJV, Gibson H, Ehsan AT, Smith JM: Prevention of postpartum hemorrhage at home birth in Afghanistan. Int J Gynaecol Obstet 2010, 108(3):276-281.
• [15]Rajbhandari S, Hodgins S, Sanghvi H, McPherson R, Pradhan YV, Baqui AH: Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: operations research study in Nepal. Int J Gynaecol Obstet 2010, 108(3):282-288.
• [16]Prata N, Ejembi C, Fraser A, Shittu O, Minkler M: Community mobilization to reduce postpartum hemorrhage in home births in northern Nigeria. Soc Sci Med 2012, 74(8):1288-1296.
• [17]Chandhiok N, Dhillon BS, Datey S, Mathur A, Saxena NC: Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. Int J Gynaecol Obstet 2006, 92(2):170-175.
• [18]World Health Organization (WHO): Unedited report of the 18th expert committee on the selection and use of essential medicines. Accra: Accra: WHO; 2011.
• [19]World Health Organization (WHO): WHO recommendations for the prevention and treatment of postpartum hemorrhag. Geneva: World Health Organization (WHO); 2012.
• [20]Descargues G, Pitette P, Gravier A, Roman H, Lemoine JP, Marpeau L: Missed diagnosis of postpartum hemorrhage. J Gynecol Obstet Biol Reprod (Paris) 2001, 30(6):590-600.
• [21]Quaiyum MA, Hossain SAS, Steatfield PK: A simple method of measuring blood loss due to post partum haemorrhage (PPH) in Bangladesh (Abstract). International Congress on Interventions to prevent post partum haemorrhage: translating research into practice. Goa; 2006.
• [22]Prata N, Quaiyum MA, Passano P, Bell S, Bohl DD, Hossain S, Azmi AJ, Begum M: Training traditional birth attendants to use misoprostol and an absorbent delivery mat in home births. Soc Sci Med 2012, 75(11):2021-2027.
• [23]Center for Disease Control and Prevention: Epi Info version 3.5.1. 351st edition. Atlanta, Georgia USA; 2008.
• [24]StataCorp: Stata survey data reference manual: release 11. College Station, TX: StataCorp LP; 2009.
• [25]Elati A, Elmahaishi MS, Elmahaishi MO, Elsraiti OA, Weeks AD: The effect of misoprostol on postpartum contractions: a randomised comparison of three sublingual doses. BJOG 2011, 118(4):466-473.
• [26]Hofmeyr GJ, Gülmezoglu AM, Novikova N, Lawrie TA: Postpartum misoprostol for preventing maternal mortality and morbidity. Cochrane Database Syst Rev 2013., 7CD008982